These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 60238)

  • 1. Preparation and properties of antisera directed against antigens of the P-815 mastocytoma cell not shared by its syngeneic host, the DBA/2 mouse.
    Bertschmann M; Clemetson KJ; Lüscher EF
    Eur J Cancer (1965); 1976 Apr; 12(4):255-62. PubMed ID: 60238
    [No Abstract]   [Full Text] [Related]  

  • 2. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 3. Solubilization of histocompatibility and tumour-associated antigens of the P-815 murine mastocytoma cell.
    Clemetson KJ; Gerber A; Bertschmann M; Lüscher EF
    Eur J Cancer (1965); 1976 Apr; 12(4):263-70. PubMed ID: 821757
    [No Abstract]   [Full Text] [Related]  

  • 4. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response.
    Kölsch E
    Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA
    Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody mediated neutralization of immunosuppression induced by mastocytoma ascites fluids.
    Watanabe M; Pan S; Friedman H
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):238-41. PubMed ID: 79184
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR; Fahey KJ
    Adv Exp Med Biol; 1973; 29(0):411-7. PubMed ID: 4211985
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics.
    Clemetson KJ; Bertschmann M; Lüscher EF
    Mol Immunol; 1981 Feb; 18(2):135-41. PubMed ID: 6167852
    [No Abstract]   [Full Text] [Related]  

  • 12. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes.
    Martz E; Benacerraf B
    J Immunol; 1973 Nov; 111(5):1538-45. PubMed ID: 4200780
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of capping H-2 antigens on the susceptibility of target cells to humoral and T cell-mediated lysis.
    Ekidin M; Henney CS
    Nat New Biol; 1973 Nov; 246(150):47-9. PubMed ID: 4202329
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte-dependent antibody in sheep immunized with murine mastocytoma cells.
    Grant CK; Adams E; Miller HR
    Eur J Immunol; 1975 May; 5(5):324-30. PubMed ID: 824135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice.
    Al-Rammahy AK; Levy JG; Jackson AL
    J Immunol; 1980 Jan; 124(1):143-50. PubMed ID: 6765966
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immune response against tumor cells. I. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells.
    Lundak RL; Raidt DJ
    Cell Immunol; 1973 Oct; 9(1):60-6. PubMed ID: 4270287
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse.
    Bertschmann M; Schären B; Lüscher EF
    Immunobiology; 1980 Jan; 156(4-5):382-99. PubMed ID: 6768671
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice.
    Greenberg AH; Playfair JH
    Clin Exp Immunol; 1974 Jan; 16(1):99-109. PubMed ID: 4143189
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of xenogeneic and allogeneic antisera specific for mouse thymus-derived lymphocytes.
    Bron C; Anckers C; Sauser D
    Eur J Immunol; 1976 Aug; 6(8):594-8. PubMed ID: 61881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.